| Entry |
|
|---|
| Symbol |
NDUFB1
|
|---|
| Name |
(RefSeq) NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 1
|
|---|
| KO |
| K03957 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex subunit 1 |
|
|---|
| Organism |
pon Pongo abelii (Sumatran orangutan)
|
|---|
| Pathway |
| pon04723 | Retrograde endocannabinoid signaling |
| pon04932 | Non-alcoholic fatty liver disease |
| pon05022 | Pathways of neurodegeneration - multiple diseases |
| pon05208 | Chemical carcinogenesis - reactive oxygen species |
|
|---|
| Module |
| pon_M00147 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex |
|
|---|
| Brite |
KEGG Orthology (KO) [BR:pon00001]
09100 Metabolism
09102 Energy metabolism
00190 Oxidative phosphorylation
100173590 (NDUFB1)
09150 Organismal Systems
09156 Nervous system
04723 Retrograde endocannabinoid signaling
100173590 (NDUFB1)
09159 Environmental adaptation
04714 Thermogenesis
100173590 (NDUFB1)
09160 Human Diseases
09161 Cancer: overview
05208 Chemical carcinogenesis - reactive oxygen species
100173590 (NDUFB1)
09164 Neurodegenerative disease
05010 Alzheimer disease
100173590 (NDUFB1)
05012 Parkinson disease
100173590 (NDUFB1)
05014 Amyotrophic lateral sclerosis
100173590 (NDUFB1)
05016 Huntington disease
100173590 (NDUFB1)
05020 Prion disease
100173590 (NDUFB1)
05022 Pathways of neurodegeneration - multiple diseases
100173590 (NDUFB1)
09166 Cardiovascular disease
05415 Diabetic cardiomyopathy
100173590 (NDUFB1)
09167 Endocrine and metabolic disease
04932 Non-alcoholic fatty liver disease
100173590 (NDUFB1)
|
|---|
| SSDB |
|
|---|
| Motif |
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| Position |
15:complement(96488545..96494211)
|
|---|
| AA seq |
58 aa
MVNLLQIVRDHWVHVLVPMGFVIGCYLDKKSDEQLTAFRNKSMLFKRGLQPNEEVTWK |
|---|
| NT seq |
177 nt +upstreamnt +downstreamnt
atggtgaacttacttcagattgtgcgggaccactgggttcatgttcttgtccctatggga
tttgtcattggatgttatttagacaaaaagagtgatgaacagttaactgccttccggaac
aagagtatgttatttaaaaggggattgcaacccaatgaagaagttacctggaagtaa |
|---|
